"Three-Bullets" Loaded Mesoporous Silica Nanoparticles for Combined Photo/Chemotherapy

Overview

Journal Nanomaterials (Basel)

Date 2019 Jun 5

PMID 31159241

Citations 5

Authors

Andre Luiz Tessaro

Aurore Fraix

Ana Claudia Pedrozo da Silva

Elena Gazzano

Chiara Riganti

Salvatore Sortino

Affiliations

Soon will be listed here.

Abstract

This contribution reports the design, preparation, photophysical and photochemical characterization, as well as a preliminary biological evaluation of mesoporous silica nanoparticles (MSNs) covalently integrating a nitric oxide (NO) photodonor (NOPD) and a singlet oxygen (O) photosensitizer (PS) and encapsulating the anticancer doxorubicin (DOX) in a noncovalent fashion. These MSNs bind the NOPD mainly in their inner part and the PS in their outer part in order to judiciously exploit the different diffusion radius of the cytotoxic NO and O. Furthermore this silica nanoconstruct has been devised in such a way to permit the selective excitation of the NOPD and the PS with light sources of different energy in the visible window. We demonstrate that the individual photochemical performances of the photoactive components of the MSNs are not mutually affected, and remain unaltered even in the presence of DOX. As a result, the complete nanoconstruct is able to deliver NO and O under blue and green light, respectively, and to release DOX under physiological conditions. Preliminary biological results performed using A375 cancer cells show a good tolerability of the functionalized MSNs in the dark and a potentiated activity of DOX upon irradiation, due to the effect of the NO photoreleased.

Citing Articles

Recent Innovations of Mesoporous Silica Nanoparticles Combined with Photodynamic Therapy for Improving Cancer Treatment.

Nady D, Hassan A, Amin M, Bakowsky U, Fahmy S Pharmaceutics. 2024; 16(1).

PMID: 38276492 PMC: 10821275. DOI: 10.3390/pharmaceutics16010014.

Recent Advances in Green Metallic Nanoparticles for Enhanced Drug Delivery in Photodynamic Therapy: A Therapeutic Approach.

Chota A, George B, Abrahamse H Int J Mol Sci. 2023; 24(5).

PMID: 36902238 PMC: 10003542. DOI: 10.3390/ijms24054808.

Stimuli Responsive Nitric Oxide-Based Nanomedicine for Synergistic Therapy.

Zhao Y, Ouyang X, Peng Y, Peng S Pharmaceutics. 2021; 13(11).

PMID: 34834332 PMC: 8622285. DOI: 10.3390/pharmaceutics13111917.

Functional Nanostructures for Sensors, Optoelectronic Devices, and Drug Delivery.

Castriciano M Nanomaterials (Basel). 2020; 10(6).

PMID: 32575371 PMC: 7353124. DOI: 10.3390/nano10061195.

Nitric Oxide-Releasing Polymeric Materials for Antimicrobial Applications: A Review.

Rong F, Tang Y, Wang T, Feng T, Song J, Li P Antioxidants (Basel). 2019; 8(11).

PMID: 31731704 PMC: 6912614. DOI: 10.3390/antiox8110556.

References

Krishna R, Mayer L . Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur J Pharm Sci. 2000; 11(4):265-83. DOI: 10.1016/s0928-0987(00)00114-7. View

Gottesman M, Fojo T, Bates S . Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer. 2002; 2(1):48-58. DOI: 10.1038/nrc706. View

Riganti C, Miraglia E, Viarisio D, Costamagna C, Pescarmona G, Ghigo D . Nitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug efflux. Cancer Res. 2005; 65(2):516-25. View

Fukumura D, Kashiwagi S, Jain R . The role of nitric oxide in tumour progression. Nat Rev Cancer. 2006; 6(7):521-34. DOI: 10.1038/nrc1910. View

Castano A, Mroz P, Hamblin M . Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer. 2006; 6(7):535-45. PMC: 2933780. DOI: 10.1038/nrc1894. View

Caruso E, Petralia S, Conoci S, Giuffrida S, Sortino S . Photodelivery of nitric oxide from water-soluble platinum nanoparticles. J Am Chem Soc. 2007; 129(3):480-1. DOI: 10.1021/ja067568d. View

Callari F, Sortino S . Amplified nitric oxide photorelease in DNA proximity. Chem Commun (Camb). 2008; (17):1971-3. DOI: 10.1039/b800132d. View

Brevet D, Gary-Bobo M, Raehm L, Richeter S, Hocine O, Amro K . Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy. Chem Commun (Camb). 2009; (12):1475-7. DOI: 10.1039/b900427k. View

Wada A, Tamaru S, Ikeda M, Hamachi I . MCM-enzyme-supramolecular hydrogel hybrid as a fluorescence sensing material for polyanions of biological significance. J Am Chem Soc. 2009; 131(14):5321-30. DOI: 10.1021/ja900500j. View

10.

Lehar J, Krueger A, Avery W, Heilbut A, Johansen L, Price E . Synergistic drug combinations tend to improve therapeutically relevant selectivity. Nat Biotechnol. 2009; 27(7):659-66. PMC: 2708317. DOI: 10.1038/nbt.1549. View

11.

Qian H, Guo H, Ho P, Mahendran R, Zhang Y . Mesoporous-silica-coated up-conversion fluorescent nanoparticles for photodynamic therapy. Small. 2009; 5(20):2285-90. DOI: 10.1002/smll.200900692. View

12.

De Boo S, Kopecka J, Brusa D, Gazzano E, Matera L, Ghigo D . iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells. Mol Cancer. 2009; 8:108. PMC: 2785770. DOI: 10.1186/1476-4598-8-108. View

13.

Ostrowski A, Ford P . Metal complexes as photochemical nitric oxide precursors: potential applications in the treatment of tumors. Dalton Trans. 2009; (48):10660-9. DOI: 10.1039/b912898k. View

14.

Celli J, Spring B, Rizvi I, Evans C, Samkoe K, Verma S . Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem Rev. 2010; 110(5):2795-838. PMC: 2896821. DOI: 10.1021/cr900300p. View

15.

Sortino S . Light-controlled nitric oxide delivering molecular assemblies. Chem Soc Rev. 2010; 39(8):2903-13. DOI: 10.1039/b908663n. View

16.

Ogilby P . Singlet oxygen: there is indeed something new under the sun. Chem Soc Rev. 2010; 39(8):3181-209. DOI: 10.1039/b926014p. View

17.

Coti K, Belowich M, Liong M, Ambrogio M, Lau Y, Khatib H . Mechanised nanoparticles for drug delivery. Nanoscale. 2010; 1(1):16-39. DOI: 10.1039/b9nr00162j. View

18.

Jain R, Stylianopoulos T . Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol. 2010; 7(11):653-64. PMC: 3065247. DOI: 10.1038/nrclinonc.2010.139. View

19.

Fry N, Mascharak P . Photoactive ruthenium nitrosyls as NO donors: how to sensitize them toward visible light. Acc Chem Res. 2011; 44(4):289-98. DOI: 10.1021/ar100155t. View

20.

Ambrogio M, Thomas C, Zhao Y, Zink J, Stoddart J . Mechanized silica nanoparticles: a new frontier in theranostic nanomedicine. Acc Chem Res. 2011; 44(10):903-13. PMC: 3196789. DOI: 10.1021/ar200018x. View